Information message

In order to see all the search results and access content, you must log in. Please use the Log-in button at the top of the page.

Displaying 61 - 72 of 433
General Hepatology

EASL Studio:Liver cirrhosis in 2023: unmet needs and how to address them? (Complete Session)

EASL Studio
View
General Hepatology

EASL Studio: The battle to reduce alcohol harms… EASL’s new policy

EASL Studio
View
General Hepatology

EASL Studio Opening

EASL Studio
View
General Hepatology

EASL Studio: Practice changing highlights from EASL Congress 2023

EASL Studio
View
General Hepatology

EASL Studio: Steatotic liver disease global consensus to change nomenclature

EASL Studio
View
General Hepatology

EASL Studio: EASL Congress 2023: Back to the future

EASL Studio
View
General Hepatology

EASL Studio: Highlights of liver cancer research at EASL Congress 2023

EASL Studio
View
General Hepatology

EASL Studio: United we stand: Global societies collaborating to beat liver disease

EASL Studio
View
Cirrhosis & Complications
EASL Studio Podcast S5 E14: Hepatic encephalopathy: Underdiagnosed and underestimated

EASL Studio Podcast S5 E14: Hepatic encephalopathy: Underdiagnosed and underestimated

Podcasts
View

EASL Studio S5 E14: Hepatic encephalopathy: Underdiagnosed and underestimated

Description

Hepatic encephalopathy (HE) is a common reversible complication of advanced liver disease characterised by a spectrum of neuropsychiatric abnormalities. Due to its insidious onset, most patients only seek treatment once complications develop, resulting in it being an underdiagnosed and underestimated condition.

This EASL Studio episode, organised in collaboration with the International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN), explores the patient journey and treatment options.

Faculty

  • Debbie Shawcross (Moderator)
  • Christian Labenz (Faculty)
  • Steve Rodrigues (Faculty)
  • Dominique Thabut (Faculty)

This EASL Studio is supported by Norgine. EASL has received no input from Norgine with regards to the content of this programme.

Related episode

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

Log in to post comments

EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

Description

In this third episode, the experts discuss the worrying burden of liver cancer in Europe and the political actions needed to invert the curve. How can deaths from liver cancer be prevented and how is EASL and the hepatology community working towards this goal? What is the European Union doing for cancer control, and which are the challenges?

 

 

Speakers

 
Peter Jepsen

Born in 1975, graduated from the medical school in Aarhus, Denmark in 2003. Since then clinical training and specialisation in hepatology, alongside training in clinical epidemiology. I have published more than 100 papers, most of them in the field of hepato-epidemiology. I currently do half-time clinical work, half-time research. My primary interests are alcoholic liver disease and hepatocellular carcinoma, most notably the value of surveillance for hepatocellular carcinoma among patients with alcoholic cirrhosis.

Pietro Fiocchi

Pietro Fiocchi is a member of the European Parliament. He is also an Italian Entrepreneur and politician. After graduating in aerospace engineering at the University of Missouri of Rolla, in 1990 he entered the Navy, serving as a Sub-lieutenant on the San Giorgio landing ship until 1992 and working with the San Marco Battalion and with the Comsubin, an Italian special forces department. After two years in the navy he began his professional activity as technical director at Ravasi Robotics, an Italian robotics company, and later as manager and technical director at Fiocchi Munizioni. In 1998 he became president and member of the board of directors of Fiocchi of America. In 2007 he founded Fiocchi UK, while in 2015 he became a member of the Board of Directors of Target, a New Zealand company producing hunting and shooting cartridges. In 2019 he has been elected as a member of the European Parliament on the Brothers of Italy list. He is member of the Special Committee on Beating Cancer, of the Committee on the Environment, Public Health and Food Safety and substitute to the Committee on Industry, Research and Energy.

Log in to post comments

EASL Policy Dialogues Episode 2: The liver, alcohol, and politics

Description

In this second episode, the experts discuss the impact of alcohol consumption on the liver and the stakes around alcohol policy. What are the key trends in Europe around alcohol consumption and alcohol-related liver disease? How can the work of the European Parliament make society a safer place, with less alcohol use? What’s the impact of the alcohol industry on politics?

 

 

Speakers

 
Frances Fitzgerald

Frances Fitzgerald is a Fine Gael MEP for Dublin City and County. She is a member of the ECON (Economic & Monetary Affairs) Committee, FEMM (Women’s Rights & Gender Equality) Committee and DEVE (Development) Committee. Frances also serves as the lead coordinator for the European People’s Party on FEMM. Prior to her election to the European Parliament in the 2019 European Elections, Frances served as a Fine Gael Parliamentarian for over 20 years. She served as a Senator and T.D. in Dublin Mid-West (2007-2019) and has previously served as a Fine Gael T.D. in Dublin South East (1992-2002). She most recently served as Tánaiste (2016-17), one of only four women to have ever held this position. She has also served as Minister for Business, Enterprise & Innovation (2017); Minister for Justice & Equality (2014-17) and was the State’s first Minister for Children & Youth Affairs (2011-14). Frances has a clear record of delivering change and reform in Ireland stemming back to her education and early career. Raised in Stillorgan, she was educated in Dominican College Sion Hill, Blackrock and the London School of Economics. She worked as a social worker and family therapist for ten years in Ballymun Child & Family Centre and in St. Ultan’s Children’s Hospital, St. James’ Hospital and the Mater Hospital. She has also worked in inner city communities in both Dublin and London.

Frank Murray

Prof. Frank Murray is Consultant Hepatologist/Gastroenterologist at Beaumont Hospital, Dublin and Associate Professor of Medicine at the Royal College of Surgeons in Ireland and EASL Policy and Public Health Committee Member. He graduated from University College Dublin in 1980 and trained in Dublin, Boston USA, and Nottingham, England. He was previously Consultant Gastroenterologist in Ninewells Hospital and Medical School, Dundee, Scotland. Prof. Frank Murray became a a Fellow of the Royal College of Physicians of Ireland in 1994, was elected to the Council in 2002, and was appointed Registrar in 2007. He was the 141st President of the Royal College of Physicians of Ireland from 2014-2017. Prof. Murray is also the former chair of both the Basic Specialist Training Committee and the Irish Committee on Higher Medical Training. He is a founding member of the RCPI/HSE EQUALS Initiative, a group which sources decommissioned medical equipment in Irish hospitals to send to hospitals in less developed countries and is partnering the development of Post-graduate Training in Zambia. Prof. Murray is Chairman of the RCPI Policy Group on Alcohol in 2102 , and Chairman of Alcohol Health Alliance Ireland in 2015. He has played a prominent national role in highlighting alcohol harm in Ireland and supported the introduction of evidence-based alcohol counter-measures, such as those in the Public health Alcohol Bill. Prof. Murray has recently been appointed Director, National Doctors Training and Planning (NDTP), HSE in Dublin.

Log in to post comments